| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Stephanie McGrath, Lisa R Bartner, Sangeeta Rao, Rebecca A Packer, Daniel L Gustafso. Randomized blinded controlled clinical trial to assess the effect of oral cannabidiol administration in addition to conventional antiepileptic treatment on seizure frequency in dogs with intractable idiopathic epilepsy. Journal of the American Veterinary Medical Association. vol 254. issue 11. 2020-07-01. PMID:31067185. |
to assess the effect of oral cannabidiol (cbd) administration in addition to conventional antiepileptic treatment on seizure frequency in dogs with idiopathic epilepsy. |
2020-07-01 |
2023-08-13 |
Not clear |
| Isaac Yao, Efrat Shavit Stein, Nicola Maggi. Cannabinoids, hippocampal excitability and efficacy for the treatment of epilepsy. Pharmacology & therapeutics. vol 202. 2020-06-29. PMID:31176695. |
this review seeks to summarize the progress made in cannabis research in the past four decades and to identify possible directions for future research that are critical for the development of cannabinoid-based therapy in epilepsy. |
2020-06-29 |
2023-08-13 |
Not clear |
| Kelly G Knupp, John D Rice, Laura J Helmkamp, Jeffrey Galinkin, Cristina Sempio, Klawitter Jost, Kevin E Chapma. Prospective evaluation of oral cannabis extracts in children with epilepsy. Seizure. vol 72. 2020-06-26. PMID:31550641. |
prospective evaluation of oral cannabis extracts in children with epilepsy. |
2020-06-26 |
2023-08-13 |
Not clear |
| Kelly G Knupp, John D Rice, Laura J Helmkamp, Jeffrey Galinkin, Cristina Sempio, Klawitter Jost, Kevin E Chapma. Prospective evaluation of oral cannabis extracts in children with epilepsy. Seizure. vol 72. 2020-06-26. PMID:31550641. |
our aim was to prospectively characterize the use of oral cannabis extracts (oce) in a refractory pediatric epilepsy population. |
2020-06-26 |
2023-08-13 |
Not clear |
| Rumi Agarwal, Shanna L Burke, Marlaina Maddu. Current state of evidence of cannabis utilization for treatment of autism spectrum disorders. BMC psychiatry. vol 19. issue 1. 2020-06-19. PMID:31664964. |
given the sparse state of evidence directly assessed in this population, studies which examined effects of cannabis on shared pathological symptoms of asd such as hyperactivity, sleep disorders, self-injury, anxiety, behavioral problems, and communication were also reviewed.studies revealed mixed and inconclusive findings of cannabis effects for all conditions, except epilepsy. |
2020-06-19 |
2023-08-13 |
Not clear |
| Daniel Friedman, Jacqueline A French, Mauro Maccarron. Safety, efficacy, and mechanisms of action of cannabinoids in neurological disorders. The Lancet. Neurology. vol 18. issue 5. 2020-06-04. PMID:30910443. |
despite positive results in these two severe epilepsy syndromes, further studies are needed to determine if the anti-seizure effects of cannabidiol extend to other forms of epilepsy, to overcome pharmacokinetic challenges with oral cannabinoids, and to uncover the exact mechanisms by which cannabidiol or other exogenous and endogenous cannabinoids exert their therapeutic effects. |
2020-06-04 |
2023-08-13 |
Not clear |
| Debopam Samant. Cannabidiol: A Review of Clinical Efficacy and Safety in Epilepsy. Pediatric neurology. vol 96. 2020-05-01. PMID:31053391. |
cannabidiol: a review of clinical efficacy and safety in epilepsy. |
2020-05-01 |
2023-08-13 |
Not clear |
| Debopam Samant. Cannabidiol: A Review of Clinical Efficacy and Safety in Epilepsy. Pediatric neurology. vol 96. 2020-05-01. PMID:31053391. |
the us food and drug administration (fda) has approved pharmaceutical-grade cannabidiol oil for two childhood-onset catastrophic epilepsies: dravet syndrome and lennox-gastaut syndrome. |
2020-05-01 |
2023-08-13 |
Not clear |
| Rikinkumar S Patel, Hema M Mekala, William E Tankersle. Cannabis Use Disorder and Epilepsy: A Cross-National Analysis of 657 072 Hospitalized Patients. The American journal on addictions. vol 28. issue 5. 2020-04-24. PMID:31124592. |
cannabis use disorder and epilepsy: a cross-national analysis of 657 072 hospitalized patients. |
2020-04-24 |
2023-08-13 |
Not clear |
| Rikinkumar S Patel, Hema M Mekala, William E Tankersle. Cannabis Use Disorder and Epilepsy: A Cross-National Analysis of 657 072 Hospitalized Patients. The American journal on addictions. vol 28. issue 5. 2020-04-24. PMID:31124592. |
we investigated the relationship between cannabis use disorder (cud) and hospitalization for epilepsy. |
2020-04-24 |
2023-08-13 |
Not clear |
| Keith A Kwan Cheung, Hassendrini Peiris, Geoffrey Wallace, Olivia J Holland, Murray D Mitchel. The Interplay between the Endocannabinoid System, Epilepsy and Cannabinoids. International journal of molecular sciences. vol 20. issue 23. 2020-04-17. PMID:31810321. |
in particular, the cannabinoid cannabidiol has been reported to have anti-convulsant and anti-inflammatory properties, and it shows promise for epilepsy treatment. |
2020-04-17 |
2023-08-13 |
Not clear |
| Angela K Birnbaum, Ashwin Karanam, Susan E Marino, Christopher M Barkley, Rory P Remmel, Michaela Roslawski, Mary Gramling-Aden, Ilo E Leppi. Food effect on pharmacokinetics of cannabidiol oral capsules in adult patients with refractory epilepsy. Epilepsia. vol 60. issue 8. 2020-04-15. PMID:31247132. |
food effect on pharmacokinetics of cannabidiol oral capsules in adult patients with refractory epilepsy. |
2020-04-15 |
2023-08-13 |
Not clear |
| Angela K Birnbaum, Ashwin Karanam, Susan E Marino, Christopher M Barkley, Rory P Remmel, Michaela Roslawski, Mary Gramling-Aden, Ilo E Leppi. Food effect on pharmacokinetics of cannabidiol oral capsules in adult patients with refractory epilepsy. Epilepsia. vol 60. issue 8. 2020-04-15. PMID:31247132. |
to evaluate the pharmacokinetics of a purified oral cannabidiol (cbd) capsule administered with and without food in adults with refractory epilepsy. |
2020-04-15 |
2023-08-13 |
Not clear |
| Kerstin A Klotz, Martin Hirsch, Marcel Heers, Andreas Schulze-Bonhage, Julia Jacob. Effects of cannabidiol on brivaracetam plasma levels. Epilepsia. vol 60. issue 7. 2020-04-14. PMID:31211851. |
the use of cannabidiol (cbd) for treatment of pharmacoresistant epilepsies is increasing. |
2020-04-14 |
2023-08-13 |
Not clear |
| Abeline Rose Watkin. Cannabinoid interactions with ion channels and receptors. Channels (Austin, Tex.). vol 13. issue 1. 2020-04-10. PMID:31088312. |
cannabidiol (cbd), the non-psychoactive component of cannabis sativa, acts on a diverse selection of membrane proteins with promising therapeutic potential in epilepsy and chronic pain. |
2020-04-10 |
2023-08-13 |
Not clear |
| Pabitra Hriday Patra, Melissa Barker-Haliski, H Steve White, Benjamin J Whalley, Sarah Glyn, Haramrit Sandhu, Nicholas Jones, Michael Bazelot, Claire M Williams, Alister James McNeis. Cannabidiol reduces seizures and associated behavioral comorbidities in a range of animal seizure and epilepsy models. Epilepsia. vol 60. issue 2. 2020-04-08. PMID:30588604. |
cannabidiol reduces seizures and associated behavioral comorbidities in a range of animal seizure and epilepsy models. |
2020-04-08 |
2023-08-13 |
Not clear |
| Richard J Huntsman, Richard Tang-Wai, Alan E Shackelfor. Cannabis for Pediatric Epilepsy. Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society. vol 37. issue 1. 2020-03-18. PMID:31895184. |
cannabis for pediatric epilepsy. |
2020-03-18 |
2023-08-13 |
Not clear |
| Richard J Huntsman, Richard Tang-Wai, Alan E Shackelfor. Cannabis for Pediatric Epilepsy. Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society. vol 37. issue 1. 2020-03-18. PMID:31895184. |
several studies have shown that cbd, both in isolation as a pharmaceutical-grade preparation or as part of a cbd-enriched cannabis herbal extract, is beneficial in decreasing seizure frequency in children with treatment-resistant epilepsy. |
2020-03-18 |
2023-08-13 |
Not clear |
| Jose F Téllez-Zenteno, Lady D Ladino, Lizbeth Hernández-Ronquill. The Use of Cannabis as a Treatment for Epilepsy in Adult Patients: Are Side Effects a Limitation of Use? Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society. vol 37. issue 1. 2020-03-18. PMID:31895185. |
the use of cannabis as a treatment for epilepsy in adult patients: are side effects a limitation of use? |
2020-03-18 |
2023-08-13 |
Not clear |
| Jose F Téllez-Zenteno, Lady D Ladino, Lizbeth Hernández-Ronquill. The Use of Cannabis as a Treatment for Epilepsy in Adult Patients: Are Side Effects a Limitation of Use? Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society. vol 37. issue 1. 2020-03-18. PMID:31895185. |
in the last few years, cannabis has been proposed as a potential therapy for patients with drug-resistant epilepsy. |
2020-03-18 |
2023-08-13 |
Not clear |